Target intelligence / Profile preview

Tripartite motif-containing protein 71 (TRIM71)

Target
TRIM71
Molecular classification
E3 ubiquitin ligase (RING-type), RNA-binding protein, Tripartite motif (TRIM) protein family, NHL domain-containing protein
01

Overview

Tripartite motif-containing protein 71 (TRIM71) is an E3 ubiquitin-protein ligase and RNA-binding protein characterized by an N-terminal RING domain (conferring E3 ligase activity) and a C-terminal NHL domain (mediating RNA binding). TRIM71 is a key post-transcriptional regulator of gene expression in embryonic stem cells and neural progenitors, functioning mainly by binding to and repressing transcripts with hairpin motifs in their 3′UTRs, either leading to target degradation or inhibiting translation. It also interacts with the microRNA (miRNA) machinery, contributing independently and synergistically with miRNAs to repress target gene expression like CDKN1A/p21, thereby promoting self-renewal, proliferation, and maintenance of undifferentiated cell states. Mutations in TRIM71 are causative of congenital hydrocephalus and may have broader implications in stem cell biology and oncogenesis.

Other names
LIN41Lin-41E3 ubiquitin-protein ligase TRIM71Protein lin-41 homologRING-type E3 ubiquitin transferase TRIM71HYC4HYDCC1abnormal cell lineage LIN-41homolog of C. elegans Lin-41
02

Mechanism of action

Facilitation of ubiquitin-mediated protein degradation (as E3 ligase); Post-transcriptional repression of mRNAs (including miRNA-dependent mechanisms); RNA hairpin recognition and direct silencing of mRNA targets

03

Biological functions

Cell cycle regulation (notably G1-S phase transition)Embryonic stem cell proliferation and maintenanceRepression of target transcripts via RNA binding and interaction with microRNA machineryPost-transcriptional mRNA repression (via 3′UTR binding)Neural progenitor cell proliferation and inhibition of premature differentiationModulation of alternative splicing
04

Disease associations

Congenital hydrocephalusPotential roles in neural developmental disordersPossible involvement in cancer (via stem cell regulation and cell cycle control)
05

Safety considerations

Disruption may impair neural development or contribute to congenital hydrocephalusTargeting in adults may affect stem cell maintenance and differentiation
06

Biomarkers

Mutations in TRIM71 in patients with congenital hydrocephalus (potential diagnostic marker)

Beyond the preview

Go deeper on Tripartite motif-containing protein 71 (TRIM71).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif-containing protein 71 (TRIM71).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call